Tumor budding in cervical carcinoma: Associations with some clinical and pathological factors
Open Access
- 1 January 2021
- journal article
- research article
- Published by National Library of Serbia in Archive of Oncology
- Vol. 27 (1) , 1-4
Abstract
Background: Tumor budding is recognized as an important independent prognostic factor in colorectal carcinoma. The aim of this study was to evaluate the grade of tumor budding and association with other clinical and pathological features in patients with cervical carcinoma. Material and methods: We evaluated pathohistological data from 91 cervical carcinoma patients (mean age: 53.8 years) who underwent radical hysterectomy and pelvic lymphatic dissection at the Oncology Institute of Vojvodina between January 2010 and December 2018. Tumor budding was evaluated in invasive front of the tumor. Based on the number of bud counts/10 high power field, three groups were formed: with no budding, with less than 15 buds, and with more than 15 buds. Results: Eighty (87.91%) of evaluated cervical carcinomas were squamous-cell type, while 12.09% were adenocarcinomas. All carcinomas were graded (HG1-HG3). Average diameter of the tumors was 25 mm (81.6% < 4 cm and 18.4% > 4 cm). Metastases in lymph nodes were present in 30 (32.9%) cases. Based on the number of bud counts/10 high power field there were 35.1% with no budding, 32.9% with less than 15 buds and 37.3% with more than 15 buds. There was a significant association between tumor budding grade and histological grade (p=0.04), as well as with tumor budding grade and the diameter of the tumor (p=0.04). Conclusion: As a quantitative measure of cancer cell dissociation, tumor budding is associated with poor prognosis in cervical carcinoma and should be considered as a prognostic factor.Keywords
This publication has 24 references indexed in Scilit:
- The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancerStrahlentherapie und Onkologie, 2018
- Introducing a novel highly prognostic grading scheme based on tumour budding and cell nest size for squamous cell carcinoma of the uterine cervixThe Journal of Pathology: Clinical Research, 2018
- The TNM classification of malignant tumours—towards common understanding and reasonable expectationsThe Lancet Oncology, 2017
- Tumor budding and E-Cadherin expression in endometrial carcinoma: Are they prognostic factors in endometrial cancer?Gynecologic Oncology, 2012
- Tumor budding as a prognostic marker in laryngeal carcinomaPathology - Research and Practice, 2010
- Tumor budding as a prognostic marker in stage-III rectal carcinomaInternational Journal of Colorectal Disease, 2007
- Pattern of invasion is of prognostic value in surgically treated cervical cancer patientsGynecologic Oncology, 2006
- Tumor Budding at the Invasive Margin Can Predict Patients at High Risk of Recurrence After Curative Surgery for Stage II, T3 Colon CancerDiseases of the Colon & Rectum, 2003
- Budding as a useful prognostic marker in pT3 well‐ or moderately‐differentiated rectal adenocarcinomaJournal of Surgical Oncology, 2003
- Tumor Size, Depth of Invasion, and Grading of the Invasive Tumor Front Are the Main Prognostic Factors in Early Squamous Cell Cervical CarcinomaGynecologic Oncology, 1999